Skip to main content
Erschienen in: Journal of Neural Transmission 10/2018

23.08.2018 | Neurology and Preclinical Neurological Studies - Short communication

Cerebrospinal fluid 5-HIAA concentrations correlate with cardiac uptake of 123I-MIBG during myocardial scintigraphy in drug naïve Parkinson’s disease

verfasst von: Hidetomo Murakami, Ken Yamamoto, Taro Yasumoto, Atsushi Kimura, Yoshiki Sakae, Shohei Nomoto, Satomi Kubota, Daishi Watanabe, Keiko Watanabe, Yu Saito, Satoshi Yano, Kenjiro Ono

Erschienen in: Journal of Neural Transmission | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

We examined the correlations between cerebrospinal fluid (CSF) concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA) and imaging assessment scores, using 123I-Ioflupane SPECT and 123I-MIBG myocardial scintigraphy in 23 drug naïve PD patients. The CSF 5-HIAA concentration correlated with the H/M ratio of the delayed image (r = 0.458, p < 0.05) and the washout rate (r = − 0.642, p < 0.01) of 123I-MIBG myocardial scintigraphy. These correlations suggest some unclarified pathophysiological links between the central serotonergic and cardiac sympathetic systems.
Literatur
Zurück zum Zitat Davidson DL, Yates CM, Mawdsley C, Pullar IA, Wilson H (1977) CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders. J Neurol Neurosurg Psychiatry 40:1136–1141CrossRefPubMedPubMedCentral Davidson DL, Yates CM, Mawdsley C, Pullar IA, Wilson H (1977) CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders. J Neurol Neurosurg Psychiatry 40:1136–1141CrossRefPubMedPubMedCentral
Zurück zum Zitat Halliday GM, Blumbergs PC, Cotton RG, Blessing WW, Geffen LB (1990) Loss of brainstem serotonin- and substance P-containing neurons in Parkinson’s disease. Brain Res 510:104–107CrossRefPubMed Halliday GM, Blumbergs PC, Cotton RG, Blessing WW, Geffen LB (1990) Loss of brainstem serotonin- and substance P-containing neurons in Parkinson’s disease. Brain Res 510:104–107CrossRefPubMed
Zurück zum Zitat Ishibashi K, Kanemaru K, Saito Y, Murayama S, Oda K, Ishiwata K, Mizusawa H, Ishii K (2010) Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson’s disease. Acta Neurol Scand 122:46–51CrossRefPubMed Ishibashi K, Kanemaru K, Saito Y, Murayama S, Oda K, Ishiwata K, Mizusawa H, Ishii K (2010) Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson’s disease. Acta Neurol Scand 122:46–51CrossRefPubMed
Zurück zum Zitat Joseph MH, Kadam BV, Risby D (1981) Simple high-performance liquid chromatographic method for the concurrent determination of the amine metabolites vanillylmandelic acid, 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, dihydroxyphenylacetic acid and homovanillic acid in urine using electrochemical detection. J Chromatogr 226:361–368CrossRefPubMed Joseph MH, Kadam BV, Risby D (1981) Simple high-performance liquid chromatographic method for the concurrent determination of the amine metabolites vanillylmandelic acid, 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, dihydroxyphenylacetic acid and homovanillic acid in urine using electrochemical detection. J Chromatogr 226:361–368CrossRefPubMed
Zurück zum Zitat McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O’Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89:88–100CrossRefPubMedPubMedCentral McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O’Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89:88–100CrossRefPubMedPubMedCentral
Zurück zum Zitat Nalivaiko E (2006) 5-HT(1A) receptors in stress-induced cardiac changes: a possible link between mental and cardiac disorders. Clin Exp Pharmacol Physiol 33:1259–1264CrossRefPubMed Nalivaiko E (2006) 5-HT(1A) receptors in stress-induced cardiac changes: a possible link between mental and cardiac disorders. Clin Exp Pharmacol Physiol 33:1259–1264CrossRefPubMed
Zurück zum Zitat Orimo S, Yogo M, Nakamura T, Suzuki M, Watanabe H (2016) (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies. Ageing Res Rev 30:122–133CrossRefPubMed Orimo S, Yogo M, Nakamura T, Suzuki M, Watanabe H (2016) (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies. Ageing Res Rev 30:122–133CrossRefPubMed
Zurück zum Zitat Politis M, Wu K, Loane C, Kiferle L, Molloy S, Brooks DJ, Piccini P (2010) Staging of serotonergic dysfunction in Parkinson’s disease: an in vivo 11C-DASB PET study. Neurobiol Dis 40:216–221CrossRefPubMed Politis M, Wu K, Loane C, Kiferle L, Molloy S, Brooks DJ, Piccini P (2010) Staging of serotonergic dysfunction in Parkinson’s disease: an in vivo 11C-DASB PET study. Neurobiol Dis 40:216–221CrossRefPubMed
Zurück zum Zitat Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRefPubMed Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRefPubMed
Zurück zum Zitat Takahashi M, Ikemura M, Oka T, Uchihara T, Wakabayashi K, Kakita A, Takahashi H, Yoshida M, Toru S, Kobayashi T, Orimo S (2015) Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease. J Neurol Neurosurg Psychiatry 86:939–944CrossRefPubMed Takahashi M, Ikemura M, Oka T, Uchihara T, Wakabayashi K, Kakita A, Takahashi H, Yoshida M, Toru S, Kobayashi T, Orimo S (2015) Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease. J Neurol Neurosurg Psychiatry 86:939–944CrossRefPubMed
Zurück zum Zitat Wester P, Bergström U, Eriksson A, Gezelius C, Hardy J, Winblad B (1990) Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases. J Neurochem 54:1148–1156CrossRefPubMed Wester P, Bergström U, Eriksson A, Gezelius C, Hardy J, Winblad B (1990) Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases. J Neurochem 54:1148–1156CrossRefPubMed
Metadaten
Titel
Cerebrospinal fluid 5-HIAA concentrations correlate with cardiac uptake of 123I-MIBG during myocardial scintigraphy in drug naïve Parkinson’s disease
verfasst von
Hidetomo Murakami
Ken Yamamoto
Taro Yasumoto
Atsushi Kimura
Yoshiki Sakae
Shohei Nomoto
Satomi Kubota
Daishi Watanabe
Keiko Watanabe
Yu Saito
Satoshi Yano
Kenjiro Ono
Publikationsdatum
23.08.2018
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 10/2018
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-018-1917-x

Weitere Artikel der Ausgabe 10/2018

Journal of Neural Transmission 10/2018 Zur Ausgabe

Neurology and Preclinical Neurological Studies - Original Article

Body height loss characterizes camptocormia in Parkinson’s disease

Neurology and Preclinical Neurological Studies - Review Article

Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.